60
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Low STYK1 expression indicates poor prognosis in gastric cancer

, , , , , & show all
Pages 6669-6676 | Published online: 06 Dec 2018

References

  • TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
  • TsaiMMWangCSTsaiCYPotential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric CancerInt J Mol Sci2016176E94527322246
  • ErtaoZJianhuiCKangWPrognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric canerTumour Biol20163710136791368527473085
  • FockKMReview article: the epidemiology and prevention of gastric cancerAliment Pharmacol Ther201440325026024912650
  • GeigerTRPeeperDSMetastasis mechanismsBiochim Biophys Acta179620092293308
  • LiuLYuXZLiTSA novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude miceCancer Res200464103491349915150103
  • HuYPWuZBJiangLSTYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinomaInt J Biochem Cell Biol201897162729413947
  • ChenPLiWMLuQClinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancerBMC Cancer20141440224894011
  • HuLChenHYCaiJSerine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancerBMC Cancer20151524625884558
  • ZhaoYYangLHeJYangHSTYK1 promotes Warburg effect through PI3K/AKT signaling and predicts a poor prognosis in nasopharyngeal carcinomaTumour Biol2017397101042831771164
  • JacksonKAOpreaGHandyJKimbroKSAberrant STYK1 expression in ovarian cancer tissues and cell linesJ Ovarian Res2009211519845955
  • ChenLMaCBianYAberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patientsOncotarget201786711133311134529340057
  • WangZQuLDengBSTYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signalingSci Rep201663320527628214
  • EdgarRDomrachevMLashAEGene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Res200230120721011752295
  • RichJNHansCJonesBGene expression profiling and genetic markers in glioblastoma survivalCancer Res200565104051405815899794
  • Cancer Genome Atlas NetworkComprehensive molecular portraits of human breast tumoursNature20124907418617023000897
  • RhodesDRYuJShankerKONCOMINE: a cancer micro-array database and integrated data-mining platformNeoplasia2004611615068665
  • KentWJSugnetCWFureyTSThe human genome browser at UCSCGenome Res2002126996100612045153
  • GyőrffyBSurowiakPBudcziesJLánczkyAOnline survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancerPLoS One2013812e8224124367507
  • SunTduWXiongHYuYWengIRenLCorrection: TMEFF2 Deregulation Contributes to Gastric Carcinogenesis and Indicates Poor Survival OutcomeClin Cancer Res20152115357226240295
  • HeJJinYChenYDownregulation of ALDOB is associated with poor prognosis of patients with gastric cancerOnco Targets Ther201696099610927785057
  • Carrasco-GarcíaESacedaMMartínez-LacaciIRole of receptor tyrosine kinases and their ligands in glioblastomaCells20143219923524709958
  • ChungSTamuraKFurihataMOverexpression of the potential kinase serine/threonine/tyrosine kinase 1 (STYK 1) in castration-resistant prostate cancerCancer Sci2009100112109211419664042
  • NirasawaSKobayashiDKondohTSignificance of serine threonine tyrosine kinase 1 as a drug resistance factor and therapeutic predictor in acute leukemiaInt J Oncol20144551867187425190507
  • LemmonMASchlessingerJCell Signaling by Receptor Tyrosine KinasesCell201014171117113420602996
  • ZwickEBangeJUllrichAReceptor tyrosine kinase signalling as a target for cancer intervention strategiesEndocr Relat Cancer20018316117311566607
  • WangYAppiah-KubiKLanTPKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cellsCell Biol Int201842101358136929935031